Bacterial pore-forming toxin (PFT)

Bacterial pore-forming toxins (PFTs) represent a major class of virulence factors produced by a wide array of pathogenic bacteria, including Staphylococcus aureus, Streptococcus pneumoniae, and Bacillus anthracis (Dal Peraro & van der Goot, 2016). These toxins are typically secreted as water-soluble monomers that recognize and bind to specific receptors or lipid motifs on host cell membranes, where they undergo significant conformational changes to assemble into stable, transmembrane pores (Los et al., 2013). The formation of these pores disrupts the selective permeability of the host cell membrane, leading to uncontrolled ion flux, ATP depletion, and eventual cell death via lysis or apoptosis (StatPearls, 2023). Beyond direct cytotoxicity, PFTs play a sophisticated role in bacterial pathogenesis by facilitating nutrient acquisition, promoting tissue invasion, and subverting the host immune response by killing leukocytes (Nature Reviews Microbiology, 2016). From a therapeutic perspective, PFTs are highly attractive targets for anti-virulence strategies; current approaches include monoclonal antibodies like Suvratoxumab that neutralize specific toxins and broad-spectrum liposomal decoys like CAL02 that mimic host membranes to trap multiple PFTs simultaneously (The Lancet Infectious Diseases, 2019).

Other names

CytolysinHemolysinPore-forming proteinBacterial PFTMembrane-damaging toxin

Therapeutic strategies involve the neutralization of toxin monomers using monoclonal antibodies to prevent membrane binding and oligomerization, or the use of biomimetic liposomal decoys to sequester toxins and prevent host cell damage.